EU GMP injectable manufacturing plant in Spain for sale
- BUSINESS OVERVIEW:
Company founded in 2005 by a group of professionals from the pharmaceutical sector with the aim to manufacture and distribute healthcare and medicinal products in the hospital field.
- BUSINESS STRENGTHS:
The company complies with the EU GMP standard for injectible line and provide contract manufacturing servise to European pharmaceutical companies. 3 additional lines in ophtalmology is on the way to get EU GMP within 2017. 提供服务: 我) Manufacturing of liquid parenteral solutions with terminal sterilization in glass, 聚丙烯容器, PP bags from a 50ml to 3 litres ii) 盖仑开发和分析 iii) 稳定性测试 iv) 营销, 物流配送. 竞争优势: 我) tax incentives due to region in Spain, 二、) 资产 iii 没有贷款) 来自地面的水, 四号) New European machineries v) lower labor costs due to region in Spain vi) possible expansion without investment
- EXPANSION OPPORTUNITY:
- Great possibilities for geographic expansion into Spain and other European markets, 中东, 非洲, 亚洲, Americas Market whereas EU GMP is acceptable.
- 3 ophtalmology lines (1 multidose, 2 minidose) on the way to get EU GMP approval in 2017.
- 90% of factory capasities are free now, so company can rapidly grow using the existing base without additional investment.
- Own land is 5.000 平方米, 建筑 2.000 平方米
- MAIN PRODUCTS (contract manufacturing services)
CIPROFLOXACIN 2 MG/ML, 100 机器学习, 200机器学习 (制药)
FLUCONAZOL 2 MG/ML, 50 机器学习 (制药)
METRONIDAZOL 5 MG/ML, 100 机器学习 (制药)
STERILE WATER, 500 机器学习, 1000机器学习, 3000机器学习 (Medical Device, CE)
SOLUCION NaCl 0.9 % – 50, 100, 250, 500, 1000, 3000 机器学习 (Medical Device, CE)
SOLUCION GLUCOSE 1.5 %, 3000 机器学习 (Medical Device, CE)
- MAIN CUSTOMERS:
Contract manufaturing servise for European pharmaceutical companies Hospitals in Spain
| 6. PROFIT AND LOSS STATEMENT, 欧元 | ||
| 2016 | 2017 | |
| TURNOVER | 300.000 | 600.000 |
| OPERATING EXPENSES | 360.000 | 360.000 |
| PROFIT / LOSS | -60.000 | 240.000 |
| 7. BALANCE, 欧元 | ||
| ASSET | 3.000.000 | |
| LAND + BUILDING | 1.500.000 | |
| MACHINERIES | 1.500.000 | |
| NO DEBTS | ||
- DEBTS:
无债务.
- NUMBER OF EMPLOYEES: 15
- TAX AND LABOR LIABILITIES:
There is no tax liability and no labor liabilities.
具体来说, in the Labour domain there is no action in progress.
- PHISICAL AREA OF THE COMPANY:
西班牙
| 土地 | 5.000 m² |
| Building | 2.000 m² |
| Monthly Rental: | No expensas, asset belongs to the company |
- GENERAL INVENTORY:
Stock:
Machinery and Equipment Fixed assets:
1.500.000 欧元
- REASON FOR SALE:
Evaluating other business opportunities.
- SELLING PRICE AND CONDITIONS:
100% value for sale (Base date: 行进 2017) = 5.000.000 欧元
100% Cash payment
- ADDITIONAL INFORMATION:
Economic and financial diagnosis and company “VALUATION” when requested shall be provided during the DUE DILIGENCE, after expressions of interest from the investor group and signed Confidentiality Agreement (NDA).
- SALES PROCESS:
- Information Memorandum distribution to Pipelinepharma networking
- Investor written confirmation of interest with a LOI (letter of intent) or NBO (non-binding offer)
- Visit a plant, meeting sellers, Due Diligence
- Binding offer
- Share transfer agreement